Related Experiment Video
Updated: Jun 27, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response
Max Koeppel1, Simon J van Heeringen, Leonie Smeenk
1Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.
Abstract:
The tumor suppressor p53 contributes to the cellular fate after genotoxic insults, mainly through the regulation of target genes, thereby allowing e.g. repair mechanisms resulting in cell survival or inducing apoptosis. Unresolved so far is the issue, which exact mechanisms lead to one or the other cellular outcome. Here, we describe the interferon regulatory factor-2-binding protein-2 (IRF2BP2) as a new direct target gene of p53, influencing the p53-mediated cellular decision. We show that upregulation of IRF2BP2 after treatment with actinomycin D (Act.D) is dependent on functional p53 in different cell lines. This occurs in parallel with the down-regulation of the interacting partner of IRF2BP2, the interferon regulatory factor-2 (IRF2), which is known to positively influence cell growth. Analyzing the molecular functions of IRF2BP2, it appears to be able to impede on the p53-mediated transactivation of the p21- and the Bax-gene. We show here that overexpressed IRF2BP2 has an impact on the cellular stress response after Act.D treatment and that it diminishes the induction of apoptosis after doxorubicin treatment. Furthermore, the knockdown of IRF2BP2 leads to an upregulation of p21 and faster induction of apoptosis after doxorubicin as well as Act.D treatment.
Insights
The tumor suppressor p53 regulates cellular fate. We identified IRF2BP2 as a new p53 target gene that influences cell survival and apoptosis by modulating p53
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The tumor suppressor p53 is crucial for cellular fate determination following genotoxic stress.
- p53 regulates target genes to promote cell survival via repair or induce apoptosis.
- The precise mechanisms dictating p53-mediated cellular outcomes remain incompletely understood.
Purpose of the Study:
- To identify novel p53 target genes that influence cellular decisions after genotoxic insults.
- To elucidate the role of interferon regulatory factor-2-binding protein-2 (IRF2BP2) in p53-mediated cellular responses.
- To investigate how IRF2BP2 affects apoptosis and cell survival pathways regulated by p53.
Main Methods:
- Analysis of IRF2BP2 expression in response to genotoxic agents (actinomycin D, doxorubicin) in cell lines with functional or non-functional p53.
- Investigation of the interaction between IRF2BP2 and IRF2.
- Assessment of IRF2BP2's impact on p53-mediated transactivation of p21 and Bax.
- Functional studies involving IRF2BP2 overexpression and knockdown to evaluate effects on cellular stress response and apoptosis.
Main Results:
- IRF2BP2 is identified as a direct p53 target gene, upregulated in a p53-dependent manner after actinomycin D treatment.
- IRF2BP2 expression correlates with the downregulation of IRF2, a known growth-promoting factor.
- Overexpression of IRF2BP2 impedes p53-mediated transactivation of p21 and Bax, reduces apoptosis induction after doxorubicin treatment, and impacts cellular stress response.
- Knockdown of IRF2BP2 enhances p21 upregulation and accelerates apoptosis induction following doxorubicin and actinomycin D treatment.
Conclusions:
- IRF2BP2 is a novel p53 target gene that plays a significant role in modulating p53-dependent cellular fate decisions.
- IRF2BP2 acts as a negative regulator of p53-mediated apoptosis and influences the expression of key apoptosis-related genes like p21 and Bax.
- IRF2BP2's function in regulating cellular stress responses and apoptosis provides new insights into the complex mechanisms governing cell survival and death pathways.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Regulation of the Unfolded Protein Response
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway

